✦ LIBER ✦

P315 Acceptance and adherence with oral endocrine therapy in women with metastatic breast cancer: ExaCampania group study

✍ Scribed by R. Addeo; P. Russo; L. Maiorino; A. Febraro; L. Leo; P. Incoronato; A. Pisano; M. Bianco; R. Mabilia; S. del Prete

Book ID: 114316650
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 51 KB
Volume: 20
Category: Article
ISSN: 0960-9776
DOI: 10.1016/s0960-9776(11)70253-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ovarian function suppression and fulvest

Ovarian function suppression and fulvestrant as endocrine therapy in premenopausal women with metastatic breast cancer

✍ Rupert Bartsch; Zsuzsanna Bago-Horvath; Anna Berghoff; Catharina DeVries; Ursula 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 302 KB

Tolerability of and adherence to combina

Tolerability of and adherence to combination oral therapy with gefitinib and capecitabine in metastatic breast cancer

✍ E. L. Mayer; A. H. Partridge; L. N. Harris; R. S. Gelman; S. T. Schumer; H. J. B 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 193 KB

Insight into Barriers Against Optimal Ad

Insight into Barriers Against Optimal Adherence to Oral Hormonal Therapy in Women with Breast Cancer

✍ Margaret C. Kirk; Clifford A. Hudis 📂 Article 📅 2008 🏛 CIG Media Group, LP. 🌐 English ⚖ 115 KB

Emotional expression and diurnal cortiso

Emotional expression and diurnal cortisol slope in women with metastatic breast cancer in supportive-expressive group therapy: A preliminary study

✍ Janine Giese-Davis; Sue DiMiceli; Sandra Sephton; David Spiegel 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 214 KB

Cohort study examining tamoxifen adheren

Cohort study examining tamoxifen adherence and its relationship to mortality in women with breast cancer

✍ Shearer, J; McCowan, C; Donnan, P T; Dewar, J A; Crilly, M; Thompson, A M; Fahey 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 119 KB

Randomized Phase III Placebo-Controlled

Randomized Phase III Placebo-Controlled Trial of Letrozole Plus Oral Temsirolimus As First-Line Endocrine Therapy in Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer

✍ Wolff, A. C.; Lazar, A. A.; Bondarenko, I.; Garin, A. M.; Brincat, S.; Chow, L.; 📂 Article 📅 2013 🏛 American Society of Clinical Oncology 🌐 English ⚖ 194 KB